secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001104659-24-071011
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio stockholders elect directors, approve equity plan amendment, ratify auditors at annual meeting
--------------------------------------------------------------------------------

- All five director nominees elected; Michael Hoffman (3,856,586 for), Maria Maccecchini (3,888,261 for), Claudine Bruck, Reid McCarthy, Mark White.
- Amendment to 2019 Equity Incentive Plan approved, adding 1,000,000 shares to the share reserve.
- Ratification of Ernst & Young as independent auditor for FY2024 approved (7,214,275 for, 48,270 against).
- 66.10% of outstanding shares (7,278,396 shares) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924071011/0001104659-24-071011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924071011/tm2417098d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-071011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer